Regulus Therapeutics Inc.

NASDAQ (USD): Regulus Therapeutics Inc. (RGLS)

Last Price

1.24

Today's Change

+0.03 (2.47%)

Day's Change

1.21 - 1.27

Trading Volume

278,990

Overview

Market Cap

81 Million

Shares Outstanding

65 Million

Avg Volume

362,306

Avg Price (50 Days)

1.49

Avg Price (200 Days)

1.78

PE Ratio

-1.22

EPS

-1.02

Earnings Announcement

19-Mar-2025

Previous Close

1.21

Open

1.21

Day's Range

1.21 - 1.27

Year Range

1.16 - 3.79

Trading Volume

278,990

Price Change Highlight

1 Day Change

2.48%

5 Day Change

-3.12%

1 Month Change

-19.48%

3 Month Change

-13.29%

6 Month Change

-29.14%

Ytd Change

-20.51%

1 Year Change

-0.80%

3 Year Change

-38.00%

5 Year Change

-89.40%

10 Year Change

-99.95%

Max Change

-99.75%

News and Blogs
Latest Hottest Following

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Regulus Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the discovery and development of drugs that targets microRNAs to treat a range of diseases in the United States. Its product candidates include RG-012, an anti-miR targeting miR-21 that is in Phase II clinical trial for the treatment of Alport syndrome, a life-threatening kidney disease; and RGLS8429, an anti-miR targeting miR-17, which is in Phase 1b clinical study for the treatment of autosomal dominant polycystic kidney disease. The company is also developing a pipeline of preclinical drug products for target organ-selective delivery strategies. Regulus Therapeutics Inc. was incorporated in 2007 and is headquartered in San Diego, California.

Discussions
Be the first to like this. Showing 1 of 1 comments

actvtrader

I like the 50.00 price target for yahoo!

2014-10-22 15:48

Post a Comment